A c c e p t e d A r t i c l e
© 2013 The Authors Aging Cell © 2013 Blackwell Publishing Ltd/Anatomical Society of GreatBritain and Ireland
(Fontan-Lozano
et al.
2008). In addition CR shows remarkable neuroprotective propertiesagainst neurodegenerative diseases including stroke, Parkinson’s disease (PD), Huntington’sdisease (HD) and Alzheimer’s Disease (AD) in several animal models (Mattson 2005; Patel
et al.
2005).Recent studies in different AD mouse models reported that reducing food intake can diminishAD-related neuropathologies and cognitive dysfunction. For example, CR reduces theprogression of
β
amyloid (A
β
) deposition in the hippocampus and cerebral cortex of AD micecarrying mutations for FAD (Wang
et al.
2005), APP (amyloid precursor protein) and APP + PS-1 (presenilin 1) (Patel
et al.
2005; Mouton
et al.
2009). CR ameliorates neurodegenerativephenotypes assessed by object recognition and contextual fear conditioning tests in cDKO(conditional double knockout) AD mice (Wu
et al.
2008). Mattson and coworkers have shownthat CR can also ameliorate age-related memory impairment and decrease A
β
andphosphorylated tau accumulation in a triple transgenic mouse (3xTg-AD) that overexpressmutations linked to AD (PS-1, APP) and frontotemporal dementia (tau) (Halagappa
et al.
2007).Also studies in human populations suggest that diet plays an important role in AD and reducedfood intake may protect against this pathology. For example, an epidemiological study byLuchsinger and colleagues provided evidence that individuals with a low calorie intake have areduced risk of developing AD (Luchsinger
et al.
2002).Among the large number of metabolic and physiological changes caused by CR, reduction ofgrowth hormone (GH)/insulin-like factor (IGF-1) signaling axis may be important for itsprotective effects (Fontana
et al.
2010). Circulating IGF-1 is a hormone produced primarily bythe liver that regulates energy metabolism, cell proliferation, cell differentiation, body size andlongevity. IGF-1 levels are regulated by calorie and/or protein availability and long-term CRdecreases serum IGF-1 concentration by approximately 30–40% in rodents (Thissen
et al.
1994) but not in humans unless protein intake is also reduced (Fontana
et al.
2008). Mutations